MUC1 in normal cells is modified with highly complex O‐glycans; however, in cancer cells, glycan elongation stops, resulting in the formation of abnormally short glycans and an increase in tumor‐associated glycans, such as Tn, T, STn, and ST antigens [17, 18]. This evidence concerns the gene MUC1 and cancer.